Healthcare-focused private equity firm BelHealth Investment Partners has promoted Nathan Kronforst to managing director and named Jonathan Spero as an associate. Prior to joining BelHealth, Kronforst worked at Celerant Capital where he served as vice president while Spero worked at SunTrust Robinson Humphrey where he was an analyst in the healthcare investment banking division.
New York, NY – March 2, 2015 – BelHealth Investment Partners, a healthcare-focused private equity firm, announced the promotion of Nathan Kronforst to Managing Director.
Mr. Kronforst joined BelHealth in 2012 as a Vice President and has been involved in the origination, structuring, due diligence and overall execution of transactions. Mr. Kronforst has had a lead role in BelHealth’s investment in Aureus Health Services and serves on the company’s Board of Directors. Prior to joining BelHealth, he was Vice President and founding member of Celerant Capital, a middle market private equity firm where he led deal origination, evaluation and structuring.
Mr. Kronforst received his MBA from the Kenan-Flagler Business School at the University of North Carolina and his BA in Business Administration and Computer Information Systems from the University of Miami.
Dennis Drislane, BelHealth Managing Partner said, “We are pleased to announce Nate’s promotion to Managing Director. He has been a tremendous member of the investment team and integral to the success BelHealth has achieved to date. Nate has earned this promotion through his tireless work on origination and portfolio company management. Nate’s future is bright and we look forward to his continued leadership with the firm.”
Additionally, BelHealth is pleased to announce that Jonathan Spero has joined the fund as an Associate. Mr. Spero will be active in executing new transactions and working closely with existing portfolio companies.
Previously, Mr. Spero worked as an Analyst in the healthcare investment banking division of SunTrust Robinson Humphrey. Mr. Spero received a bachelor’s degree in Business Administration and Finance from Carnegie Mellon University.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies that would benefit from BelHealth’s vast operating and private equity experience. The firm typically invests $20-40 million per platform company across four healthcare segments: Services, Distribution, Products and Information Technology. Applying an active, hands-on approach, BelHealth utilizes its experience to support management, drive revenue and profit growth and achieve superior returns for its investors and partners.